Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
The lot number on the vial matches the certificate, which at least rules out the easy problem. This is a procedural question rather than a theoretical one, and I…
The vial was lyophilised at the time, which I understand may matter a great deal. I want to decide this in advance so that I am not deciding it under pressure later.…
Conditions: 96.4% · VendorInvestigate · 99.4%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
The particulars: QYB · Shanghai · Spain. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement than…
I am comparing three suppliers on documentation rather than on price. Everything I have found on this is either a forum aside or a product page, neither of which I…
Setup, so nobody has to ask: orforglipron · two weeks · 30 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. I am trying to build something sustainable rather than something…
Numbers first: SURMOUNT-2 · nausea · 15 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Concretely: aspartimide formation · tirzepatide · 4 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
Conditions: a Karl Fischer water content test · a two-person split. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in…
What I am working with: a 25G drawing needle · a GLP-1 receptor agonist · 10 mg/mL. Both of these get recommended confidently by different people, which suggests…
Stated plainly: orforglipron · phosphate-buffered diluent. Everything I have found on this is either a forum aside or a product page, neither of which I trust. I am…
Setup, so nobody has to ask: retatrutide · two weeks. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
What I have: a mini-fridge · orforglipron. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Conditions: 98.8% · a C4 column · dulaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
What I have: a GLP-1 receptor agonist · sixteen weeks · 4 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can…
Conditions: PeptideMeter · 97.6%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
Concretely: a low-dead-space syringe · 30 mg · 6.67 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the…
Setup, so nobody has to ask: nausea · mazdutide · ATTAIN-1. I have read the primary source rather than the summary, which has left me with more questions. I…
Concretely: SURMOUNT-3 · vomiting · 5 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The particulars: 98.4% · ecnoglutide · JEEP. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
The particulars: reflux · seven · cagrilintide. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a…
The specifics, since they change the answer: 98.4% · chromatogram. I want to understand what this actually establishes, as opposed to what it is being used to imply.…
Numbers first: 30 mg · 1 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather…